InvestSMART

Dimerix Limited (ASX: DXB) - Announcements

Current share price for DXB : $0.213 0.008 (3.41%)+

ASX company news and announcements for Dimerix Limited (DXB) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Dimerix Limited (DXB) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Dimerix Limited (DXB), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Dimerix Limited (DXB)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$129 Trial Update Presentation 5 Mar 2019 8:23AM $0.084 $0.215 risen by 155.95%
$129 Half Year Report & DMX-200 Clinical Trials Update 26 Feb 2019 8:27PM $0.087 $0.215 risen by 147.13%
$129 Half Yearly Report and Accounts 26 Feb 2019 8:23PM $0.087 $0.215 risen by 147.13%
$129 Appendix 4C and Quarterly Highlights 31 Jan 2019 9:02AM $0.088 $0.215 risen by 144.32%
$129 Appendix 3B 29 Jan 2019 4:18PM $0.089 $0.215 risen by 141.57%
$129 Appendix 3B 14 Jan 2019 5:45PM $0.088 $0.215 risen by 144.32%
$129 Dimerix Receives R&D Tax Cash Rebate Totalling $1.07m 20 Dec 2018 9:37AM $0.088 $0.215 risen by 144.32%
$129 Change of Director's Interest Notice 27 Nov 2018 9:40AM $0.092 $0.215 risen by 133.70%
$129 Appendix 3B 27 Nov 2018 8:22AM $0.092 $0.215 risen by 133.70%
$129 Dimerix Awarded $50,000 Innovation Connections Grant 26 Nov 2018 9:18AM $0.093 $0.215 risen by 131.18%
$129 1st Patient Dosed in DMX-200 Clinical Trial for FSGS 22 Nov 2018 8:27AM $0.098 $0.215 risen by 119.39%
$129 DXB Receives Orphan Drug Designation in EU 21 Nov 2018 9:42AM $0.094 $0.215 risen by 128.72%
$129 Change of Address 12 Nov 2018 8:29AM $0.100 $0.215 risen by 115%
$129 Results of Meeting 30 Oct 2018 1:52PM $0.110 $0.215 risen by 95.45%
$129 AGM Presentation and CEO Address 30 Oct 2018 11:44AM $0.110 $0.215 risen by 95.45%
$129 Appendix 4C - quarterly 29 Oct 2018 6:22PM $0.115 $0.215 risen by 86.96%
$129 AGM Dial-In Details 25 Oct 2018 8:31AM $0.120 $0.215 risen by 79.17%
$129 Investor Update 15 Oct 2018 8:23AM $0.098 $0.215 risen by 119.39%
$129 Appendix 3B 24 Sep 2018 9:25AM $0.110 $0.215 risen by 95.45%
$129 Notice of Annual General Meeting/Proxy Form 21 Sep 2018 7:29PM $0.110 $0.215 risen by 95.45%
$129 Change of Director's Interest Notice 11 Sep 2018 10:02AM $0.115 $0.215 risen by 86.96%
$129 Annual Report to shareholders 30 Aug 2018 1:14PM $0.099 $0.215 risen by 117.17%
$129 Appendix 4G and Corporate Governance Statement 30 Aug 2018 1:14PM $0.099 $0.215 risen by 117.17%
$129 Preliminary Final Report 30 Aug 2018 1:10PM $0.099 $0.215 risen by 117.17%
$129 Initial Director's Interest Notice 28 Aug 2018 11:52AM $0.097 $0.215 risen by 121.65%

551 - 575 of 746 results

Page 23 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.